Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment
Ping Lü(Xiamen University), Toshitaka Nabeshima(Fujita Health University), Takashi Ikejima(Shenyang Pharmaceutical University), Takayoshi Mamiya(Meijo University), Lingling Lu(Shenyang Pharmaceutical University), Taku Nagai(Fujita Health University), Minae Niwa(Nagoya University), Kiyofumi Yamada(Fujita Health University), Hyoung‐Chun Kim(Kangwon National University), Li-Bo Zou(Shenyang Pharmaceutical University), Akihiro Mouri(Fujita Health University)
Cited by 96
Related Papers
Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment
|Neurochemistry International|2007|266
Blonanserin Ameliorates Phencyclidine-Induced Visual-Recognition Memory Deficits: the Complex Mechanism of Blonanserin Action Involving D3-5-HT2A and D1-NMDA Receptors in the mPFC
|Neuropsychopharmacology|2014|202
Silibinin prevents amyloid β peptide‐induced memory impairment and oxidative stress in mice
|British Journal of Pharmacology|2009|199